Tierra Biosciences
PrivateLast Round
Series A
Mar 12, 2024
Total Funding Raised
$14M
Momentum Score
50 /100
Company Overview
Tierra Biosciences is a biotechnology company that provides a predictive AI-guided, cell-free platform for high-throughput, on-demand custom protein synthesis for customers in the pharmaceutical, agricultural, and industrial sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tierra Biosciences Comps
Public and private peers based on sector, stage, and business model.
Tierra Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2024 | ||||
| Seed | Sep 11, 2018 |
Tierra Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creative Ventures | Series A |
| Material Impact | Series A |
| Social Capital | Series A, Seed |
| Hillspire | Series A |
| Prosus Ventures | Series A |
| Freeflow Ventures | Series A |
| KdT Ventures | Seed |
Tierra Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tierra Biosciences's valuation, stock price, and market status.